Trial Profile
Pharmacokinetic study of bictegravir in combination with rifampin in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Apr 2018
Price :
$35
*
At a glance
- Drugs Bictegravir/emtricitabine/tenofovir alafenamide (Primary) ; Rifampicin
- Indications HIV-1 infections
- Focus Adverse reactions; Pharmacokinetics
- 23 Apr 2018 New trial record
- 07 Mar 2018 Results presented at the 25th Conference on Retroviruses and Opportunistic Infections